Abstract:DDX58/RIG-I, is a critical pattern recognition receptor for viral RNA, which plays an essential role in antiviral immunity. Its posttranslational modifications and stability are tightly regulated to mediate the moderate production of type I IFN to maintain the immune homeostasis. Recently, we reported that macroautophagy/autophagy balances type I IFN signaling through selective degradation of ISG15-associated DDX58 via LRRC25. However, the regulatory mechanism about the autophagic degradation of DDX58 remains largely undefined. Here, we identified LRRC59 as a vital positive regulator of DDX58-mediated type I IFN signaling. Upon virus infection, LRRC59 specifically interacted with ISG15-associated DDX58 and blocked its association with LRRC25, the secondary receptor to deliver DDX58 to autophagosomes for SQSTM1/p62-dependent degradation, leading to the stronger antiviral immune responses. Thus, our study reveals a novel regulatory role of selective autophagy in innate antiviral responses mediated by the cross-regulation of LRRC family members. These data further provide insights into the crosstalk between autophagy and innate immune responses.Abbreviations: ATG: Autophagy-related; Baf A1: Bafilomycin A1; DDX58/RIG-I: DEAD [Asp-Glu-Ala-Asp] box polypeptide 58; EV: Empty vector; IC poly[I:C]: Intracellular polyriboinosinic polyribocytidylic acid; IFIH1/MDA5: Interferon induced with helicase C domain 1; IFN: Interferon; ISG15: ISG15 ubiquitin like modifier; IKBKE: Inhibitor of nuclear factor kappa B kinase subunit epsilon; IRF3: Interferon regulatory factor 3; KO: Knockout; LRRC: Leucine rich repeat containing; MAVS: Mitochondrial antiviral signaling protein; CGAS/MB21D1: Cyclic GMP-AMP synthase; SeV: Sendai virus; siRNA: small interfering RNA; SQSTM1/p62: Sequestosome 1; TBK1: TANK binding kinase 1; TLR: Toll like receptor; TMEM173/STING: Transmembrane protein 173; VSV: Vesicular stomatitis virus; WT: Wild type

HSCARG Negatively Regulates the Cellular Antiviral RIG-I Like Receptor Signaling Pathway by Inhibiting TRAF3 Ubiquitination via Recruiting OTUB1

NBR1 Mediates Autophagic Degradation of IRF3 to Negatively Regulate Type I Interferon Production.

Estrogen Receptor Alpha Inhibits RLR-mediated Immune Response Via Ubiquitinating TRAF3.

The E3 Ubiquitin Ligase Triad3A Negatively Regulates the RIG-I/MAVS Signaling Pathway by Targeting TRAF3 for Degradation

HSCARG downregulates NF-κB signaling by interacting with USP7 and inhibiting NEMO ubiquitination

LTN1 promotes RLR degradation to inhibit immune response to RNA virus through the ESCRT pathway

HSCARG Inhibits Activation of NF-κB by Interacting with IκB Kinase-Β

Negative Regulation of RIGI-Mediated Innate Antiviral Signaling by SEC 14 L 1

Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3

SRP54 Negatively Regulates IFN-Beta Production and Antiviral Response by Targeting RIG-I and MDA5

LRRC59 modulates type I interferon signaling by restraining the SQSTM1/p62-mediated autophagic degradation of pattern recognition receptor DDX58/RIG-I

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

Hscarg Inhibits Activation Of Nf-Kappa B By Interacting With I Kappa B Kinase-Beta

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

Selective autophagy controls the stability of transcription factor IRF3 to balance type I interferon production and immune suppression

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

RTN3 inhibits RIG-I-mediated antiviral responses by impairing TRIM25-mediated K63-linked polyubiquitination

The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response

Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS

HSCARG Regulates NF-κB Activation by Promoting the Ubiquitination of RelA or COMMD1*